LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Evolv Technologies Holdings, Inc. ("Evolv" or "the Company") (NASDAQ: EVLV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 19, 2022 and October 30, 2024, inclusive (the "Cla ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Evolv To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in Evolv between August 19, 2022 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Nov. 8, 2024 /PRNewswire/ -- ...

Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives due to alleged material misstatements in financial statements impacting revenue recognition and other metrics [1][3][4] Group 1: Lawsuit Details - The lawsuit is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Evolv's securities [2] - The case is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2] - Investors have until December 31, 2024, to request to be appointed to lead the case [2] Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition [3][4] - The company disclosed that certain sales were subject to extracontractual terms not communicated to accounting personnel, and misconduct was involved in these transactions [4] Group 3: Stock Price Impact - Following the announcement of the financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4] - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5] Group 4: Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs in this case [7] - The firm operates on a contingency fee basis, meaning there are no upfront costs for shareholders [6]

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Evolv Technologies Holdings, Inc. ("Evolv Technologies Holdings, Inc." or the "Company") (NASDAQ: EVLV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Evolv Technologies Holdings, Inc. investors who were adversely affected by alleged securities fraud between August 19, 2022 and October 30, 2024. Follow the link below to get more information and be contacted by a member ...

NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ: EVLV) and certain of its officers.Class DefinitionThis lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise ...

ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or “the Company”) (NASDAQ: EVLV). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information, including allegations that Evolv’s sales, including sales to one of its largest channel partners, were subject to extra-contractual terms and conditions not shared with the Company’s accounting ...

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) securities between August 19, 2022 and October 30, 2024. Evolv is a security technology company that utilizes AI-based screening designed to help create safer experiences. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired Evolv securities between August 19, 2022 and October 30, 2024, both dates inclusive (the “Class Period”). ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all persons or entities who purchased or otherwise acquired Evolv Technologies Holdings, Inc. (“Evolv Technologies” or the “Company”) (Nasdaq: EVLV) securities between August 19, 2022 and October 30, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s in ...

Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives, alleging material misstatements in financial statements related to revenue recognition from Q2 2022 to Q2 2024 [1][2][3] Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2] - Investors have until December 31, 2024, to request to lead the case [2] Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition and other metrics [3] - On October 25, 2024, Evolv announced that its financial statements should not be relied upon due to these misstatements, revealing issues with sales to a major channel partner and misconduct by certain personnel [4] Group 3: Stock Price Impact - Following the announcement of financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4] - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5] Group 4: Legal Representation - Bleichmar Fonti & Auld LLP is representing plaintiffs in this case, with no upfront costs for shareholders [6][7] - The firm has a strong track record, having recovered over $900 million from Tesla's Board of Directors and $420 million from Teva Pharmaceutical Industries [8]